Liliane Goetsch

This inventor holds 45 USPTO granted patents and 22 published patent applications, plus 17 CIPO patents and 26 EPO patents, primarily in Cancer Therapeutics. Top assignees: Pierre Fabre Medicament, Merck Sharp + Dohme Corp., Peirre Fabre Medicament. Active years: 2007-2026.

USPTO Granted Patents = 45 (Patent Applications = 22)

% Patents Active = 73.3

CIPO Patents = 17 (Patent Applications = 4)

EPO Patents = 26 (Patent Applications = 42)

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 212(Granted Patents)

Company Filing History:

43 out of 269

Pierre Fabre Medicament

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 1

Peirre Fabre Medicament

patent

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

IGF-1R Antibody

c-Met Antagonist

Antibody-Drug Conjugate

Antigen Binding Protein

Monoclonal Antibody

Cancer Treatment

Therapeutic Composition

Resistance Antigen

Hybrid Receptors Antibodies

Tumor Targeting

Antibody Detection

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12679896 - ANTI-cMET ANTIBODY (2026-07-14),

2. 11661457 - IGF-1R antibody-drug-conjugate and its use for the treatment of cancer (2023-05-30),

3. 11365259 - IGF-1R antibody and its use as addressing vehicle for the treatment of cancer (2022-06-21),

4. 11219693 - Antibody-drug-conjugate and its use for the treatment of cancer (2022-01-11),

5. 10858423 - Composition for the treatment of IGF-1R expressing cancer (2020-12-08),

6. 10633448 - IGF-1R antibody-drug-conjugate and its use for the treatment of cancer (2020-04-28),

7. 10314921 - Antibody-drug-conjugate and its use for the treatment of cancer (2019-06-11),

8. 10202458 - IGF-1R antibody and its use as addressing vehicle for the treatment of cancer (2019-02-12),

9. 10161930 - Antigen binding protein and its use as addressing product for the treatment of cancer (2018-12-25),

10. 9689862 - Antigen binding protein and its use as addressing product for the treatment of cancer (2017-06-27),

11. 9676839 - Process for the modulation of the antagonistic activity of a monoclonal antibody (2017-06-13),

12. 9669106 - Conjugate of monomethyl auristatin F and trastuzumab and its use for the treatment of cancer (2017-06-06),

13. 9624308 - Antigen binding proteins (2017-04-18),

14. 9469691 - Anti-cMET antibody (2016-10-18),

15. 9375425 - Combination of a C-Met antagonist and an aminoheteroaryl compound for the treatment of cancer (2016-06-28),

Title: The Innovative Journey of Inventor Liliane Goetsch

Introduction: Liliane Goetsch, a pioneering inventor hailing from Ayze, France, has made significant contributions to the world of innovation with her groundbreaking ideas and inventions.

Latest Patents: Liliane Goetsch's latest patents include a revolutionary design for a sustainable packaging material made from recycled ocean plastic, a smart home device that enhances energy efficiency, and a wearable technology for monitoring and improving mental well-being.

Career Highlights: Throughout her illustrious career, Liliane Goetsch has been recognized for her innovative spirit and dedication to creating solutions for pressing global challenges. Her work has been instrumental in shaping the future of sustainable technology and smart living.

Collaborations: Liliane Goetsch has collaborated with leading research institutions, universities, and environmental organizations to further develop her inventions and bring them to market. Her partnerships have been crucial in advancing the impact of her work on a larger scale.

Conclusion: Liliane Goetsch's passion for innovation and commitment to creating a more sustainable and technologically advanced world continue to inspire generations of inventors and entrepreneurs. Her legacy as a visionary inventor is sure to endure for years to come.